Artemisinin Blocks Prostate Cancer Growth and Cell Cycle Progression by Disrupting Sp1 Interactions with the Cyclin-dependent Kinase-4 (CDK4) Promoter and Inhibiting CDK4 Gene Expression
Open Access
- 1 January 2009
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 284 (4), 2203-2213
- https://doi.org/10.1074/jbc.m804491200
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Sp1: Regulation of gene expression by phosphorylationGene, 2005
- Artemisinin: an alternative treatment for oral squamous cell carcinoma.2004
- Inhibition of human cancer cell line growth and human umbilical vein endothelial cell angiogenesis by artemisinin derivatives in vitroPharmacological Research, 2003
- 3,3′-Diindolylmethane (DIM) induces a G1 cell cycle arrest in human breast cancer cells that is accompanied by Sp1-mediated activation of p21WAF1/CIP1 expressionCarcinogenesis: Integrative Cancer Research, 2002
- Transferrin overcomes drug resistance to artemisinin in human small-cell lung carcinoma cellsCancer Letters, 2002
- Indole-3-carbinol Inhibits CDK6 Expression in Human MCF-7 Breast Cancer Cells by Disrupting Sp1 Transcription Factor Interactions with a Composite Element in the CDK6 Gene PromoterPublished by Elsevier BV ,2001
- The anti-malarial artesunate is also active against cancerInternational Journal of Oncology, 2001
- Core Promoter Specificities of the Sp1 and VP16 Transcriptional Activation DomainsMolecular and Cellular Biology, 1995
- The retinoblastoma protein and cell cycle controlCell, 1995
- A cDNA encoding a pRB-binding protein with properties of the transcription factor E2FCell, 1992